Connection

Kent Armeson to Cohort Studies

Back to Details
This is a "connection" page, showing publications Kent Armeson has written about Cohort Studies.
Kent Armeson
Connection Strength
0.136
Cohort Studies
  1. Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
    View in: PubMed
    Score: 0.032
  2. Comparison of psychosocial factors over time among HPV+ oropharyngeal cancer and tobacco-related oral cavity cancer patients. Am J Otolaryngol. 2019 Jan - Feb; 40(1):40-45.
    View in: PubMed
    Score: 0.026
  3. IGHG, IGKC, and FCGR genes and endogenous antibody responses to GARP in patients with breast cancer and matched controls. Hum Immunol. 2018 Aug; 79(8):632-637.
    View in: PubMed
    Score: 0.025
  4. Cervical esophageal cancer: a population-based study. Head Neck. 2015 Jun; 37(6):808-14.
    View in: PubMed
    Score: 0.019
  5. Plasma sphingolipids and lung cancer: a population-based, nested case-control study. Cancer Epidemiol Biomarkers Prev. 2013 Aug; 22(8):1374-82.
    View in: PubMed
    Score: 0.018
  6. Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest. 2011 Dec; 140(6):1550-1556.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.